Evidence map›Paper›PMID 26896941›Full record

Observational studyEuropean journal of clinical pharmacology2016

Drug-related mortality among inpatients: a retrospective observational study.

Alfredo José Pardo Cabello, Esperanza Del Pozo Gavilán, Francisco Javier Gómez Jiménez, Carmen Mota Rodríguez, Juan de Dios Luna Del Castillo, Emilio Puche Cañas

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of clinical pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Drug-related deaths among inpatients: a meta-analysis.European journal of clinical pharmacology · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Potential drug-drug interactions in deceased inpatients.Internal and emergency medicine · 2019
    Observational
  18. Article
  19. Medications Without Harm?Oman medical journal · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alfredo José Pardo CabelloDepartment of Internal Medicine, San Cecilio University Hospital, Avda. Dr. Olóriz n°16, 18012, Granada, Spain. apardoc05@yahoo.es.
Esperanza Del Pozo GavilánDepartment of Pharmacology, School of Medicine, Biomedical Research Institute ibs. Granada, University of Granada, Granada, Spain.
Francisco Javier Gómez JiménezDepartment of Medicine, School of Medicine, University of Granada, Granada, Spain.
Carmen Mota RodríguezSchool of Health Sciences of the University of Granada, Granada, Spain.
Juan de Dios Luna Del CastilloDepartment of Biostatistics, School of Medicine, University of Granada, Granada, Spain.
Emilio Puche CañasClinical Pharmacology Unit of San Cecilio University Hospital, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHospital mortality related to adverse drug reactions (ADRs) is a relevant clinical problem with major health and economic consequences. We conducted a study to assess hospital mortality related to ADRs, the drugs most frequently involved, and the possible risk factors associated with fatal ADRs.

methodsA retrospective observational study was conducted, reviewing the clinical records of 1388 consecutive adult patients (18-101 years) who died during a 22-month period in a tertiary hospital in Southern Europe (Granada, Spain). The main outcome was the prevalence of hospital death suspected to be related to administered drugs.

resultsOut of the 1388 adult deaths studied, 256 (18.4 %) were suspected of being related to drugs. Drugs were suspected of causing death in 146 inpatients (10.5 %) and contributing to death in 110 (7.9 %). Drugs related to death were administered during the hospital stay in 161 cases (11.5 %) and before hospital admission in 95 (6.84 %). The most frequent fatal ADRs were cardiac arrhythmia, gastrointestinal bleeding, and respiratory failure. The drugs most frequently involved in fatal ADRs were antithrombotics (anticoagulants or antiplatelets) (23 %), psychotropic drugs (21.2 %), and digoxin (11.3 %). Independent risk factors for ADR-related death were the presence of ≥4 diseases (OR = 1.43) and the receipt of ≥10 drugs (OR = 3.24), but no significant association with gender or age was found.

conclusionsA high percentage of hospital deaths were suspected of being associated with ADRs, especially in patients with comorbidity and/or polypharmacy. Antithrombotics, psychotropics, and digoxin were the drugs most frequently associated with in-hospital drug-related deaths.

Indexed as

Hospital MortalityAdolescentAdultAgedAged, 80 and overDigoxinDrug-Related Side Effects and Adverse ReactionsFemaleFibrinolytic AgentsHumansInpatientsMaleMiddle AgedPsychotropic DrugsSpainYoung AdultDigoxinFibrinolytic AgentsPsychotropic DrugsAdverse drug reactionsEpidemiologyHospital mortalityInpatients

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.